Ching C. Lau - Concepedia

Author

Ching C. Lau

Baylor College of Medicine ORCID

Also Known As

A. Huang, C C Lau, C Lau, C. C. Lau, C. Lau, C.C. Lau, Ching C Lau, Ching C. Lau, Ching Lau, Ching, YP

352

Publications

18.1K

Citations

H-Index

110

Concepts

All Affiliations

Baylor College of Medicine Children's Cancer Center The University of Texas MD Anderson Cancer Center Texas Children's Hospital Memorial Sloan Kettering Cancer Center

About

Ching C. Lau is an author at Baylor College of Medicine specializing in medicine, tumor biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	28	5.2K
2	Engineering	4	4	2.9K
3	Health Sciences	3	3	343
4	Public Health	3	3	170
5	Social Sciences	1	1	56

Ching C. Lau

Publications

11.6K

Citations

H-Index

Page 1

	Year	Citations
Prediction of central nervous system embryonal tumour outcome based on gene expression Scott L. Pomeroy, Pablo Tamayo, Michelle Gaasenbeek, Nature Neuro-oncologyDevelopmental BiologyEngineeringGliomaTumor Heterogeneity	2002	2.4K
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer Matthew D. Burstein, Anna Tsimelzon, Graham M. Poage, Clinical Cancer Research	2014	1.3K
Genome-wide association study identifies five susceptibility loci for glioma Sanjay Shete, Fay J. Hosking, Lindsay B. Robertson, Nature Genetics Genome-wide Association StudyGeneticsGenetic EpidemiologyDisease Gene IdentificationMedicine	2009	784
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan, European Journal of Cancer	2019	700
Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations Margaret C. Thompson, Christine Fuller, Twala L. Hogg, Journal of Clinical Oncology	2006	669
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial Neyssa Marina, Sigbjørn Smeland, Stefan Bielack, The Lancet Oncology	2016	511
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment Jeremy Whelan, Stefan Bielack, Neyssa Marina, Annals of Oncology	2014	321
A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma Peikai Chen, Yubo Fan, Tsz‐Kwong Man, BMC Bioinformatics	2013	297
Frequent Amplification of a chr19q13.41 MicroRNA Polycistron in Aggressive Primitive Neuroectodermal Brain Tumors Meihua Li, Kyle F. Lee, Yuntao Lu, Cancer Cell Tumor BiologyNeuro-oncologyFrequent AmplificationMedicinePathology	2009	239
Germline Mutations in Shelterin Complex Genes Are Associated With Familial Glioma Matthew N. Bainbridge, Georgina Armstrong, M. Monica Gramatges, JNCI Journal of the National Cancer Institute EngineeringGeneticsPathologyCommon Brain TumorMolecular Genetics	2014	223

Page 1